A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
Pfizer
Checkpoint Therapeutics, Inc.
Celldex Therapeutics
Seagen Inc.
Fate Therapeutics
Tocagen Inc.
University of Wisconsin, Madison
Lytix Biopharma AS
sigma-tau i.f.r. S.p.A.
Wuxi No. 4 People's Hospital
Valerio Therapeutics
Washington University School of Medicine
University of Chicago
Altor BioScience
Memorial Sloan Kettering Cancer Center
Cancer Research UK
Case Comprehensive Cancer Center